Latest Insider Transactions at Alnylam Pharmaceuticals, Inc. (ALNY)
This section provides a real-time view of insider transactions for Alnylam Pharmaceuticals, Inc. (ALNY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ALNYLAM PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ALNYLAM PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 23
2023
|
Amy W Schulman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
136
+50.0%
|
-
|
|
Feb 10
2023
|
Akshay Vaishnaw President |
SELL
Open market or private sale
|
Direct |
38,044
-20.25%
|
$8,179,460
$215.29 P/Share
|
|
Feb 10
2023
|
Akshay Vaishnaw President |
BUY
Exercise of conversion of derivative security
|
Direct |
30,913
+36.83%
|
$1,947,519
$63.0 P/Share
|
|
Feb 03
2023
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,424
-38.94%
|
$790,944
$231.01 P/Share
|
|
Feb 02
2023
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,601
-8.77%
|
$360,225
$225.94 P/Share
|
|
Feb 02
2023
|
Indrani Lall Franchini EVP, CLO & Secretary |
SELL
Open market or private sale
|
Direct |
1,675
-8.93%
|
$376,875
$225.94 P/Share
|
|
Feb 01
2023
|
Tolga Tanguler EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,025
+50.0%
|
-
|
|
Feb 01
2023
|
Indrani Lall Franchini EVP, CLO & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
5,175
+50.0%
|
-
|
|
Dec 05
2022
|
Akshay Vaishnaw President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,324
-5.65%
|
$299,224
$226.2 P/Share
|
|
Dec 05
2022
|
Akshay Vaishnaw President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,079
+7.22%
|
$325,056
$64.72 P/Share
|
|
Nov 21
2022
|
Dennis A Ausiello Director |
SELL
Open market or private sale
|
Direct |
22,500
-100.0%
|
$4,950,000
$220.0 P/Share
|
|
Nov 21
2022
|
Dennis A Ausiello Director |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+41.67%
|
$1,597,500
$71.09 P/Share
|
|
Aug 15
2022
|
Phillip A Sharp Director |
SELL
Open market or private sale
|
Direct |
33,670
-50.35%
|
$7,710,430
$229.93 P/Share
|
|
Aug 15
2022
|
Phillip A Sharp Director |
BUY
Exercise of conversion of derivative security
|
Direct |
33,670
+29.91%
|
$1,548,820
$46.98 P/Share
|
|
Aug 05
2022
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,841
-39.28%
|
$403,179
$219.65 P/Share
|
|
Aug 04
2022
|
Yvonne Greenstreet Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,002
-5.7%
|
$1,224,408
$204.92 P/Share
|
|
Aug 04
2022
|
Akshay Vaishnaw President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,052
-6.38%
|
$1,240,660
$205.35 P/Share
|
|
Aug 04
2022
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
5,086
-5.79%
|
$1,032,458
$203.89 P/Share
|
|
Aug 04
2022
|
Jeffrey V. Poulton EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,054
-9.14%
|
$1,031,016
$204.99 P/Share
|
|
Aug 04
2022
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,788
-26.52%
|
$357,600
$200.13 P/Share
|
|
Aug 03
2022
|
Yvonne Greenstreet Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,095
+16.28%
|
-
|
|
Aug 03
2022
|
Akshay Vaishnaw President |
BUY
Grant, award, or other acquisition
|
Direct |
13,183
+18.18%
|
-
|
|
Aug 03
2022
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
11,311
+16.81%
|
-
|
|
Aug 03
2022
|
Jeffrey V. Poulton EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,325
+26.46%
|
-
|
|
Aug 03
2022
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,754
-32.58%
|
$368,340
$210.0 P/Share
|
|
Aug 03
2022
|
Tolga Tanguler EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,629
+40.27%
|
-
|
|
Jul 05
2022
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,754
-50.0%
|
$263,100
$150.0 P/Share
|
|
Apr 01
2022
|
Steven M Paul Director |
SELL
Open market or private sale
|
Direct |
15,000
-22.96%
|
$2,580,000
$172.8 P/Share
|
|
Apr 01
2022
|
Steven M Paul Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+48.39%
|
$165,000
$11.33 P/Share
|
|
Feb 09
2022
|
Phillip A Sharp Director |
SELL
Open market or private sale
|
Direct |
30,000
-100.0%
|
$4,500,000
$150.0 P/Share
|
|
Feb 09
2022
|
Phillip A Sharp Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
$330,000
$11.33 P/Share
|
|
Feb 02
2022
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,518
-30.2%
|
$218,592
$144.67 P/Share
|
|
Feb 01
2022
|
Tolga Tanguler EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,026
+50.0%
|
-
|
|
Dec 23
2021
|
Akshay Vaishnaw President |
SELL
Open market or private sale
|
Direct |
2,879
-1.32%
|
$547,010
$190.24 P/Share
|
|
Dec 22
2021
|
Yvonne Greenstreet Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,538
-5.19%
|
$477,144
$188.88 P/Share
|
|
Dec 22
2021
|
John Maraganore Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,636
-0.95%
|
$1,247,568
$188.55 P/Share
|
|
Dec 22
2021
|
Akshay Vaishnaw President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,538
-5.13%
|
$477,144
$188.7 P/Share
|
|
Dec 21
2021
|
Yvonne Greenstreet Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,417
+24.78%
|
-
|
|
Dec 21
2021
|
John Maraganore Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,167
+5.7%
|
-
|
|
Dec 21
2021
|
Akshay Vaishnaw President |
BUY
Grant, award, or other acquisition
|
Direct |
5,417
+24.57%
|
-
|
|
Dec 10
2021
|
John Maraganore Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,367
+0.61%
|
$461,562
$86.69 P/Share
|
|
Nov 12
2021
|
John Maraganore Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
33,978
-2.87%
|
$5,844,216
$172.3 P/Share
|
|
Nov 12
2021
|
John Maraganore Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,978
+12.02%
|
$237,846
$7.1 P/Share
|
|
Aug 13
2021
|
John Maraganore Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
33,979
-2.83%
|
$6,761,821
$199.85 P/Share
|
|
Aug 13
2021
|
John Maraganore Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,979
+12.02%
|
$237,853
$7.1 P/Share
|
|
Aug 09
2021
|
Akshay Vaishnaw President |
SELL
Open market or private sale
|
Direct |
10,834
-49.14%
|
$2,166,800
$200.0 P/Share
|
|
Aug 09
2021
|
Akshay Vaishnaw President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,834
+32.95%
|
$682,542
$63.0 P/Share
|
|
Aug 06
2021
|
Yvonne Greenstreet Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
53,064
-82.8%
|
$10,559,736
$199.0 P/Share
|
|
Aug 06
2021
|
Yvonne Greenstreet Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
53,064
+34.93%
|
$4,085,928
$77.1 P/Share
|
|
Aug 05
2021
|
Laurie Keating EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-66.09%
|
$1,880,000
$188.95 P/Share
|